跳至主要内容
临床试验/NCT00110656
NCT00110656已完成不适用

A Retrospective Follow Up Study to Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

Amgen0 个研究点目标入组 38 人开始时间: 2004年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Amgen
入组人数
38
主要终点
PTH Values

研究概览

简要总结

The purpose of this study is to collect local laboratory data on immunoreactive parathyroid hormone (iPTH), calcium and phosphorus levels and estimated glomerular filtration rate (GFR) at approximately 1 week, 1 month, 3 months, 6 months and 12 months after the kidney transplant.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who withdrew from one of the qualifying studies (i.e. patient previously took part in an Amgen study investigating the drug AMG 073 and its effects on secondary hyperparathyroidism [HPT]; in particular parathyroid hormone [PTH], calcium and phosphorus levels in blood associated with kidney failure) due to kidney transplantation.

排除标准

  • Patient has any kind of disorder that compromises the ability of the subject to give written informed consent

结局指标

主要结局

PTH Values

时间窗: 12 months post kidney translplant

次要结局

  • Calcium and Phosphorus(12 months post kidney transplant)

研究者

发起方
Amgen
申办方类型
Industry

相似试验